![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CASC21-GCNT2 (FusionGDB2 ID:HG103021164TG2651) |
Fusion Gene Summary for CASC21-GCNT2 |
![]() |
Fusion gene information | Fusion gene name: CASC21-GCNT2 | Fusion gene ID: hg103021164tg2651 | Hgene | Tgene | Gene symbol | CASC21 | GCNT2 | Gene ID | 103021164 | 2651 |
Gene name | cancer susceptibility 21 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | |
Synonyms | CARLO2|CARLo-2|LINC01244 | CCAT|CTRCT13|GCNT2C|GCNT5|IGNT|II|NACGT1|NAGCT1|ULG3|bA360O19.2|bA421M1.1 | |
Cytomap | ('CASC21')('GCNT2') 8q24.21 | 6p24.3-p24.2 | |
Type of gene | ncRNA | protein-coding | |
Description | cancer susceptibility 21 (non-protein coding)cancer susceptibility candidate 21 (non-protein coding)long intergenic non-protein coding RNA 1244 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferaseI beta-1,6-N-acetylglucosaminyltransferaseIi blood groupbeta-1,6-N-acetylglucosaminyltransferase 2glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | |||
Fusion gene scores | * DoF score | 0 X 0 X 0=0 | 10 X 11 X 4=440 |
# samples | 0 | 11 | |
** MAII score |